ZERO - The Project to End Prostate Cancer
ABOUT PROSTATE CANCERGET INVOLVEDPROGRAMSRESEARCHPARTNERSSTOREABOUT US
Risk Factors
Prevention
Detection
Diagnosis
Treatment
New Prostate Cancer Research
Prostate Cancer Resources
Managing Bone Metastases and Pain
Side Effects of Prostate Cancer Treatment

Prostate Cancer Grade

Grade is a measure of how aggressive your cancer is - how likely it is to spread quickly.


  In this section:
Decisions Overview
Build Your Team
Prostate Cancer Grade
Prostate Cancer Stage
Prognosis
Treatment Option Tools
Questions to Ask

Cell samples from your biopsy are analyzed by a pathologist.

The pathologist looks at the cell samples, and analyzes how much the cancer cells look differerent from healthy cells.


Grading


Healthier cells have clearly defined outlines and fairly uniform shapes. The more aggressive the cancer, the more irregular and spread out the cells look.

The pathologist grades two types of cells from your samples, the type of cell that appears most often in all your samples, and the type that appears the least often. Each type gets a Gleason grade from 1-5, 1 being the healthiest, 5 the most cancerous.

The two grades are added together to form your Gleason score.

What Gleason scores mean:

Gleason Score Grade Meaning
2 to 4 Low Suggests a cancer that may grow slowly enough to not threaten the patient’s life.
5 to 7 Intermediate Suggests further analysis may be needed before treatment decisions should be made.
8 to 10 High Suggests a more serious threat.

Grading is also sometimes referred to as pathological stage, which just means ‘the stage determined by a pathologist examining cells under a microscope’, as opposed to clinical stage, which means ‘the stage determined by a doctor examining a patient in a clinic’.

It is very important to get an accurate picture of the cancer's grade, as this is a very important factor in deciding when and how to undergo treatment. Improving on this level of accuracy is a major focus of scientific research.

In the future, analysis of genes (genomics) or proteins (proteomics) in cancer cell or blood samples may be able to tell you exactly how your cancer is likely to behave, based on previous behavior of cancers bearing the same genetic patterns, or the types and amounts of proteins found and how they behave. The research is very new, but could have a lot of impact.

About Prostate Cancer  |  Donate  |  Get Involved  |  Programs  |  Research   |  Partners  |  Store  |  About Us  |  Site Map  |  Contact Us  |  Privacy PolicySubscribe to the ZERO Prostate Cancer News Feed  

© Copyright 2009, ZERO - The Project to End Prostate Cancer. All rights reserved.

ZERO does not endorse any course of treatment for men with prostate cancer or other conditions. Treatment decisions should be made by a patient and his health
service provider. If you have problems with the site or need more information, please call us at 1.888.245.9455 or e-mail your comments. All names, logos and articles
are the copyrights of the respective owners.